Physician profile
Morris S Dees, III
NPI 1982609392
$570.96
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.70 · 2020: $34.12 · 2021: $113 · 2022: $379 · 2023: $19.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $19.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $159.82 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $92.55 | 2022 | |
| Abbott Laboratories | $54.29 | 2022-2023 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $53.81 | 2021-2022 | |
| Novo Nordisk INC | $41.71 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.72 | 2020-2022 | |
| Pfizer INC. | $28.14 | 2021-2022 | |
| Hikma Pharmaceuticals USA | $20.54 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.23 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $16.39 | 2020 | |
| Corcept Therapeutics | $15.46 | 2021 | |
| Philips North America LLC | $14.63 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.60 | 2022 | |
| Janssen Pharmaceuticals, INC | $11.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morris Dees listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.